Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.3999
-0.0001 (-0.03%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Alps Group Market Cap
Alps Group has a market cap or net worth of $66.54 million as of September 17, 2026. Its market cap has increased by 52.14% in one year.
Market Cap
66.54M
Enterprise Value
66.68M
1-Year Change
52.14%
Ranking
Category
Stock Price
$0.40
ChartMarket Cap Chart
Since December 23, 2021, Alps Group's market cap has decreased from $143.00M to $66.54M, a decrease of -53.47%. That is a compound annual growth rate of -14.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 66.54M | -54.00% |
| Dec 31, 2025 | 144.67M | 230.19% |
| Dec 30, 2024 | 43.81M | -50.64% |
| Dec 29, 2023 | 88.76M | -41.77% |
| Dec 30, 2022 | 152.44M | 6.93% |
| Dec 30, 2021 | 142.56M | -0.30% |
| Dec 23, 2021 | 143.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 69.97M |
| Champions Oncology | 69.87M |
| OKYO Pharma | 69.27M |
| Rein Therapeutics | 68.08M |
| Alterity Therapeutics | 66.12M |
| XBiotech | 65.85M |
| LeonaBio | 65.43M |
| Spero Therapeutics | 65.22M |